Location History:
- Kobenhavn v, DK (2016)
- Copenhagen, DK (2017)
Company Filing History:
Years Active: 2016-2017
Title: Innovations of Anders M Sorensen in RNA Interference
Introduction
Anders M Sorensen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of molecular biology, particularly in the development of short interfering RNA (siRNA) analogues. With a total of 2 patents, his work focuses on advancing therapeutic agents for cancer treatment.
Latest Patents
Anders M Sorensen's latest patents involve novel double-stranded short interfering (siRNA) analogs that comprise locked nucleic acid (LNA) monomers. These compounds induce sequence-specific post-transcriptional gene silencing in various organisms through a process known as RNA interference (RNAi). The siRNA analogs he has developed show improved properties compared to non-modified siRNAs, making them potentially useful as therapeutic agents in treating various forms of cancer. Each siRNA analog consists of a sense strand and an antisense strand, with each strand containing 12-35 nucleotides and at least one locked nucleic acid (LNA) monomer.
Career Highlights
Anders M Sorensen is currently associated with Roche Innovation Center Copenhagen A/S, where he continues to innovate in the field of RNA technology. His work has garnered attention for its potential applications in medical therapies, particularly in oncology.
Collaborations
Anders collaborates with Claes Wahlestedt, a fellow researcher, to further explore the applications of siRNA technology in therapeutic settings.
Conclusion
Anders M Sorensen's contributions to the field of RNA interference through his innovative siRNA analogs highlight the potential for advancements in cancer treatment. His work exemplifies the intersection of science and technology in addressing critical health challenges.